Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Ashland Q2 Net Profit Plummets - Quick Facts

RELATED NEWS
Trade ASH now with 

Ashland Inc. (ASH: Quote) reported a significant plunge in its second-quarter net income to $88 million or $1.10 per share from last year's $485 million or $6.02 per share. However, excluding key items, Ashland's adjusted earnings from continuing operations rose 57 percent to $1.52 per share from $0.97 per share a year ago.

On average, 10 analysts polled by Thomson Reuters expected earnings per share of $1.39 for the quarter. Analysts' estimates typically exclude one-time items.

Sales for the second quarter improved to $2.08 billion from $1.56 billion in the prior-year quarter, whereas 8 analysts estimated revenues of $2.08 billion for the quarter.

The company stated, "We are well on track for the year and remain confident in our ability to deliver our fiscal 2014 financial targets for sales and earnings growth."

Click here to receive FREE breaking news email alerts for Ashland Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.